# Test and Evaluation of Non-Invasive Neuro-Assessment Devices (NINAD): NeuroKinetics, Inc, iPAS

> **NCT03165968** · — · SUSPENDED · sponsor: **Uniformed Services University of the Health Sciences** · enrollment: 150 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DEVICE:** Neuro Kinetics, Inc, i-PAS

## Key facts

- **NCT ID:** NCT03165968
- **Lead sponsor:** Uniformed Services University of the Health Sciences
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-02-22
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 150 (ESTIMATED)
- **Why stopped:** COVID19 epidemic, and institutional guidelines for halt of recruitment during epidemic
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03165968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03165968, "Test and Evaluation of Non-Invasive Neuro-Assessment Devices (NINAD): NeuroKinetics, Inc, iPAS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03165968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*